European DLB consortium: diagnostic and prognostic biomarkers in dementia with Lewy bodies, a multicenter international initiative

Neurodegener Dis Manag. 2019 Oct;9(5):247-250. doi: 10.2217/nmt-2019-0016.

Ketil Oppedal^{1

2

3}, Miguel G Borda^{1

4

5}, Daniel Ferreira⁶, Eric Westman^{6

7}, Dag Aarsland^{1

8}; European DLB Consortium

¹ Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway.
² Department of Radiology, Stavanger University Hospital, Stavanger, Norway.
³ Department of Electrical Engineering & Computer Science, University of Stavanger, Stavanger, Norway.
⁴ Faculty of Health Sciences, University of Stavanger, Stavanger, Norway.
⁵ Semillero de Neurociencias y Envejecimiento, Ageing Institute, Medical School, Pontificia Universidad Javeriana, Bogotá, Colombia.
⁶ Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Sweden.
⁷ Department of Neuroimaging, Centre for Neuroimaging Sciences, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
⁸ Department of Old Age Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

No abstract available

Keywords: E-DLB; European DLB consortium; biomarkers; dementia with Lewy bodies; diagnosis.

Publication types